Denosumab: a new option in the treatment of bone metastases from urological cancers
Authors:
- Takeshi YuasaTYTakeshi Yuasa
- Shinya YamamotoSYShinya Yamamoto
- Shinji UrakamiSUShinji Urakami
- Iwao FukuiIFIwao Fukui
- Junji YoneseJYJunji Yonese
Open Access
- 1 September 2012
- journal article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. 5, 221-9
Abstract
Peer reviewed article authored by (Yuasa T, Yamamoto S, Urakami S, Fukui I, Yonese J). Read article or submit your manuscript for publishing.Keywords
This publication has 63 references indexed in Scilit:
- Cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- Side effects of androgen deprivation therapy: monitoring and minimizing toxicityUrology, 2003
- A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate CarcinomaJNCI: Journal of the National Cancer Institute, 2002
- Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabineCancer, 2002
- Studies on Prostatic Cancer: I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the ProstateJournal of Urology, 2002
- Clinical predictors of androgen-independent prostate cancer and survival in the prostate-specific antigen eraUrology, 2002
- Chemoprevention of superficial bladder cancerCritical Reviews in Oncology/Hematology, 2002
- Locally advanced and metastatic bladder cancerCurrent Treatment Options in Oncology, 2001
- The skeletal metastatic complications of renal cell carcinomaInternational Journal of Oncology, 2001
- The role of bisphosphonates in breast cancer: Development of bisphosphonatesBreast Cancer Research, 2001